Cargando…
Effect of Immunomodulating Adjuvant Dzherelo (Immunoxel) in HIV Infected Patients Receiving Standard Antiretroviral Therapy
Open-label, matched-case, comparative trial was conducted in 40 HIV-infected patients to evaluate the adjunct effect of Dzherelo (Immunoxel) on immune and viral parameters. Arm A (n=20) received anti-retroviral therapy (ART) consisting of zidovudine, lamivudine, and efavirenz and arm B (n=20) receiv...
Autores principales: | Nikolaeva, Lyudmila G, Maystat, Tatiana V, Volyanskii, Yuri L, Pylypchuk, Volodymyr S, Frolov, Valery M, Kutsyna, Galyna A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703473/ https://www.ncbi.nlm.nih.gov/pubmed/19572055 http://dx.doi.org/10.2174/1874357900903010031 |
Ejemplares similares
-
Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients
por: Nikolaeva, Lyudmila G, et al.
Publicado: (2009) -
Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials
por: Kitenge, Marcel, et al.
Publicado: (2021) -
Peculiarities of diagnostics of billiary hypertension in patients with complicated forms of chronic pancreatitis
por: Pylypchuk, Volodymyr
Publicado: (2018) -
Synthetic Biology-derived triterpenes as efficacious immunomodulating adjuvants
por: Tateno, Mizuki, et al.
Publicado: (2020) -
THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
por: Retnakumar, Sruthi Vijaya, et al.
Publicado: (2023)